RecruitingPhase 3NCT05849597

Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery

Sponsor

University of Novi Sad

Enrollment

200 participants

Start Date

Mar 1, 2022

Study Type

INTERVENTIONAL

Conditions

Intensive Care Unit Delirium

Summary

This is a prospective, randomized, single blinded, controlled clinical trial designed to compare the clinical effects of sedation with dexmedetomidine versus propofol in patients undergoing cardiac surgery.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexmedetomidine and a drug called Propofol for people with intensive care unit delirium. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexmedetomidine

Upon arrival to the intensive care unit after open heart surgery, the patients will be sedated with continuous dexmedetomidine infusion in doses 0.2-0.7 mcg/kg/h.

DRUGPropofol

Upon arrival to the intensive care unit after open heart surgery, the patients will be sedated with continuous propofol infusion in doses 1-2 mg/kg/h.

Locations(1)

Institute of Cardiovascular Diseases of Vojvodina

Kamenitz, Serbia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05849597

Related Trials

Prevention of Delirium in ICU Using Multimodal Interventions

NCT059509581 location

Virtual Reality Cognitive Intervention for Critically Ill Delirium Survivors (VR-Cog)

NCT074962551 location